NorthWest Biotherapeutics Inc (NWBO)

[FatCat_Banker]

Allow me to tip your balance.

At the risk of driving a point to ciritcal mass, ad nauseum, or what have you, it's a combination of things that are 'encouraging'.

The use of the word "encouraged," in reference to whatever data they have so far, does not tickle my fancy. I've seen my share of encouragement in my time and it's never based on firm ground, in fact, it's to establish such.

She said it in conjunction with a notice that we're submitting, with MD Anderson co-authoring/investigating, an abstract to ASCO. So early in trail, we are submitting a Trail In Progress to a prestigious organization to review, in part with the aforementioned prestigious hospital.

Direct is used, if I've read correctly, without chemo, so, again if I'm interpreting this right, they've seen necrosis (end point one) or, even better, systemic response (end point two). It's significant that a remedy, outside the standard of care, with little to no toxicity, could reach one or both of said end points.

A double-tap, you don't submit failing or indeterminate data for review.